Influenza virus and intracellular signalling pathways;Influenzaviren und intrazelluläre signalwege

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 119, Issue 3-4, 2006, Pages 101-111

  Planz, Oliver ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Apoptosis; IFN ; Influenza virus; Intracellular signalling; MAPK

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INS1 PROTEIN, INFLUENZA VIRUS; INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; VIRUS PROTEIN;

ANIMAL; APOPTOSIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; ORTHOMYXOVIRUS; PATHOGENICITY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; HUMANS; INTERFERON TYPE I; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; ORTHOMYXOVIRIDAE; PROTEIN KINASE C; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 33644935893     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Akira, S., K. Takeda (2004): Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
2. Albert, M., B. Sauter, N. Bhardwaj (1998): Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-39.
3. Arora, D. J. S., N. Gasse (1998): Influenza virus hemagglutinin stimulates the protein kinase C activity of human polymorphonuclear leucocytes. Arch. Virol. 143, 2029-2037.
4. Balachandran, S., P. C. Roberts, T. Kipperman, K. N. Bhalla, R. W. Compans, D. R. Archer, G. N. Barber (2000): Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J.Virol. 74, 1513-1523.
5. Bergmann, M., A. Garcia-Sastre, E. Camero, H. Pehamberger, K. Wolff, P. Palese, T. Muster (2000): Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74, 6203-6206.
6. Bernasconi, D., C. Amici, S. La Frazia, A. Ianaro, M. G. Santoro (2005): The I kappa B kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J. Biol. Chem. 280, 24127-24134.
7. Bonizzi, G. M. Karin (2004): The two NF-kappa B activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
8. Bourteele, S., K. Oesterle, S. Pleschka, G. Unterstab, C. Ehrhardt, T. Wolff, S. Ludwig, O. Planz (2005): Constitutive activation of the transcription factor NF-kappa B results in impaired Borna disease virus replication. J. Virol. 79, 6043-6051.
9. Brydon, E. W. A., H. Smith, and C. Sweet (2003): Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. J. Gen. Virol. 84, 2389-2400.
10. Cai, H., U. Smola, V. Wixler, I. Eisenmann Tappe, M. T. DiazMeco, J. Moscat U. Rapp, G. M. Cooper (1997): Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell. Biol. 17, 732-741.
11. Chen, W. S., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, P. Henklein, J. R. Bennink, J. W. Yewdell (2001): A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7, 1306-1312.
12. Chou, M. M., W. M. Hou, J. Johnson, L. K. Graham, M. H. Lee, C. S. Chen, A. C. Newton, B. S. Schaffhausen, and A. Toker (1998): Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Current Biol. 8, 1069-1077.
13. Chu, Z. L., Y. A. Shin, J. M. Yang, J. A. DiDonato, D. W. Ballard (1999): IKK gamma mediates the interaction of cellular I kappa B kinases with the tax transforming protein of human T cell leukemia virus type 1. J. Biol. Chem. 274, 15297-15300.
14. Cohen, G. M. (1997): Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
15. Constantinescu, S. N., C. D. Cernescu, L. M. Popescu (1991): Effects of Protein-Kinase-C Inhibitors on Viral Entry and Infectivity. Febs Letters 292, 31-33.
16. Dauber, B., G. Heins, T. Wolff (2004): The influenza B virus nonstructural NSI protein is essential for efficient viral growth and antagonizes beta interferon induction. J. Virol. 78, 1865-1872.
17. Delhase, M., M. Hayakawa, Y. Chen, M. Karin (1999): Positive and negative regulation of I kappa B kinase activity through IKK beta subunit phosphorylation. Science 284, 309-313.
18. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, C. R. E. Sousa (2004): Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531.
19. Dong, C., R. J. Davis, R. A. Flavell (2002): MAP kinases in the immune response. Annual Rev. Immunol. 20, 55-72.
20. Durbin, J. E., R. Hackenmiller, M. C. Simon, D. E. Levy (1996): Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease. Cell 84, 443-450.
21. Edelmann, K. H., S. Richardson-Burns, L. Alexopoulou, K. L. Tyler, R. A. Flavell, M. B. A. Oldstone (2004): Does Toll-like receptor 3 play a biological role in virus infections? Virol. 322, 231-238.
22. Faleiro, L., Y. Lazebnik (2000): Caspases disrupt the nuclear-cytoplasmic barrier. J. Cell Biol. 151, 951-959.
23. Fesq, H., M. Bacher, M. Nain, D. Gemsa (1994): Programmed Cell-Death (Apoptosis) in Human Monocytes Infected by Influenza-A Virus. Immunobiol. 190, 175-182.
24. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, J. Maniatis (2003): IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunology Immunol. 4, 491-496.
25. Flory, E., M. Kunz, C. Scheller, C. Jassoy, R. Stauber, U. R. Rapp, S. Ludwig (2000): Influenza virus-induced NF-kappa B-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of I kappa B kinase. J. Biol. Chem. 275, 8307-8314.
26. Garcia-Sastre, A. (2004): Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. Biology of Negative Strand Rna Viruses: the Power of Reverse Genetics 283, 249-280.
27. Garcia-Sastre, A., R. K. Durbin, H. Y. Zheng, P. Palese, R. Gertner, D. E. Levy, J. E. Durbin (1998): The role of interferon in influenza virus tissue tropism. J. Virol. 72, 8550-8558.
28. Gibbs, J. S., D. Malide, F. Hornung, J. R. Bennink, J. W. Yewdell (2003): The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J. Virol. 77, 7214-7224.
29. Gil, J., M. Esteban (2000): Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action. Apoptosis 5, 107-114.
30. Guillot, L., R. Le Goffic, S. Bloch, N. Escriou, S. Akira, M. Chignard, M. Si-Tahar (2005): Involvement of toll-like receptor 3 in the immune response of lung evithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280, 5571-5580.
31. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, S. Bauer (2004): Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529.
32. Hinshaw, V. S., C. W. Olsen, N. Dybdahlsissoko, D. Evans (1994): Apoptosis - A Mechanism of Cell-Killing by Influenza-A and Influenza-B Viruses. J. Virol. 68, 3667-3673.
33. Hiscott, J., H. Kwon, P. Genin (2001): Hostile takeovers: viral appropriation of the NF-kappa B pathway. J. Clin. Invest. 107, 143-151.
34. Janicke, R. U., M. L. Sprengart, M. R. Wati, A. G. Porter (1998): Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol.Chem. 273, 9357-9360.
35. Kang, D. C., R. V. Gopalkrishnan, L. Lin, A. Randolph, K. Valerie, S. Pestka, P. B. Fisher (2004): Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23, 1789-1800.
36. Karin, M., Y. Ben Neriah (2000): Phosphorylation meets ubiquitination: The control of NF-kappa B activity. Ann. Rev. Immunol. 18, 621-663.
37. Karin, M., M. Delhase (2000): The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Sem. Immunol. 12, 85-98.
38. Karin, M., Z. G. Liu, E. Zandi (1997): AP-1 function and regulation. Curr. Opin. Cell. Biol. 9, 240-246.
39. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira (2005): Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28.
40. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, S. Akira (2005): IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988.
41. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marme, U. R. Rapp (1993): Protein Kinase-C-Alpha Activates Raf-1 by Direct Phosphorylation. Nature 364, 249-252.
42. Krug, R. M., W. M. Yuan, D. L. Noah, A. G. Latham (2003): Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309, 181-189.
43. Kujime, K., S. Hashimoto, Y. Gin, K. Shimizu, T. Horie (2000): p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J. Immunol. 164, 3222-3228.
44. Lee, D. C. W., C. Y. Cheung, A. H. Y. Law, C. K. P. Mok, M. Peiris, A. S. Y. Lau (2005): p38 mitogen-activated protein kinase-dependent hyper-induction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J. Virol. 79, 10147-10154.
45. Lee, F. S., R. T. Peters, L. C. Dang, T. Maniatis (1998): MEKK1 activates both I kappa B kinase alpha and I kappa B kinase beta. Proc. Natl. Acad. Sci. 95, 9319-9324.
46. Leib, D. A., M. A. Machalek, B. R. G. Williams, R. H. Silverman, H. W. Virgin (2000): Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci.PNAS 97, 6097-6101.
47. Lin, C. B., R. E. Holland, J. C. Donofrio, M. H. Mccoy, L. R. Tudor, T. M. Chambers (2002): Caspase activation in equine influenza virus induced apoptotic cell death. Vet. Microbiol. 84, 357-365.
48. Lopez, C. B., B. Moltedo, L. Alexopoulou, L. Bonifaz, R. A. Flavell, T. M. Moran (2004): TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J. Immunol. 173, 6882-6889.
49. Lorusso, P., S. Krishnamurthi, J. R. Rinehart, L. Nabell, G. Croghan, M. Varterasian, S. S. Sadis, S. S. Menon, J. Leopold, M. B. Meyer (2005): Phase 1-2 clinical study of a second generation oral MEK inhibitor, PD 0325901 in patients with advanced cancer. J. Clin. Oncol. 23, 194S.
50. Lu, Y., X. Y. Qian, R. M. Krug (1994): The Influenza-Virus Ns1 Protein - A Novel Inhibitor of Pre-Messenger-Rna Splicing. Genes Dev. 8, 1817-1828.
51. Ludwig, S., C. Ehrnardt, E. R. Neumeier, M. Kracht, U. R. Rapp, S. Pleschka (2001): Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 276, 10990-10998.
52. Ludwig, S., O. Planz, S. Pleschka, T. Wolff (2003): Influenza-virus- induced signaling cascades: targets for antiviral therapy? Trends Mol. Med. 9, 46-52.
53. Ludwig, S., S. Pleschka, T. Wolff (1999): A fatal relationship - Influenza virus interactions with the host cell. Viral Immunol. 12, 175-196.
54. Ludwig, S., T. Wotff, C. Ehrhardt, W. J. Wurzer, J. Reinhardt, O. Planz, S. Pleschka (2004): MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. Febs Letters 561, 37-43.
55. Majde, J. A. (2000): Viral double-stranded RNA, cytokines, and the flu. J. Interferon & Cytokine Res. 20, 259-272.
56. Maruoka, S., S. Hashimoto, Y. Gon, H. Nishitoh, I. Takeshita, Y. Asai, K. Mizumura, K. Shimizu, H. Ichijo, T. Horie (2003): ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem. & Biophys. Res. Commun. 307, 870-876.
57. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, R. Tschopp (2005): Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172.
58. Mizumura, K., S. Hashimoto, S. Maruoka, Y. Gon, N. Kitamura, K. Matsumoto, S. Hayashi, K. Shimizu, T. Horie (2003): Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E-2 from arachidonic acid in bronchial epithelial cells. Clin. & Exp. Allergy 33, 1244-1251.
59. Mori, I., F. Goshima, T. Koshizuka, N. Koide, T. Sugiyama, T. Yoshida, T. Yokochi, Y. Nishiyama, Y. Kimura (2003): Differential activation of the c-Jun N-terminal kinase/stress-activated protein kinase and p38 mitogen-activated protein kinase signal transduction pathways in the mouse brain upon infection with neurovirulent influenza A virus. J. Gen.Virol. 84, 2401-2408.
60. Mori, I., T. Komatsu, K. Takeuchi, K. Nakakuki, M. Sudo, Y. Kimura (1995): In-Vivo Induction of Apoptosis by Influenza-Virus. J. Gen. Virol. 76, 2869-2873.
61. Nemoto, S., J. A. DiDonato, A. N. Lin 1998): Coordinate regulation of I kappa B kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappa B-inducing kinase. Mol. & Cell. Biol. 18, 7336-7343.
62. Neumann, G. Y. Kawaoka (1999): Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes. Adv. Virus Res. 53, 265-300.
63. Nimmerjahn, F., D. Dudziak, U. Dirmeier, G. Hobom, A. Riedel, M. Schlee, L. M. Staudt, A. Rosenwald, U. Behrends, G. W. Bornkamm, J. Mautner (2004): Active NF-kappa B signalling is a prerequisite for influenza virus infection. J. Gen.Virol. 85, 2347-2356.
64. Olschlager, V., S. Pleschka, T. Fischer, H. J. Rziha, W. Wurzer, L. Stitz, U. R. Rapp, S. Ludwig, O. Planz (2004): Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 23, 6639-6646.
65. Olsen, C. W., J. C. Kehren, N. R. DybdahlSissoko, V. S. Hinshaw (1996): bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J.Virol. 70, 663-666.
66. Pahl, H. L. (1999): Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 18, 6853-6866.
67. Pahl, H. L. P. A. Baeuerle (1995): Expression of Influenza-Virus Hemagglutinin Activates Transcription Factor Nf-Kappa-B. J. Virol. 69, 1480-1484.
68. Pearson, G., J. M. English, M. A. White, M. H. Cobb (2001): ERK5 and ERK2 cooperate to regulate NF-kappa B and cell transformation. J. Biol. Chem. 276, 7927-7931.
69. Planz, O., S. Pleschka, S. Ludwig (2001): Mek-specific inhibitor u0126 blocks spread of boma disease virus in cultured cells. J. Virol 75, 4871-4877.
70. Pleschka, S., T. Wolff, C. Ehrhardt, G. Hobom, O. Planz, U. R. Rapp, S. Ludwig (2001): Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3, 301-305.
71. Razvi, E. S. R. M. Welsh (1995): Apoptosis in Viral-Infections. Advan. Virus Res.search 45, 1-60.
72. Reinhardt, J. T. Wolff (2000): The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet. Microbiol. 74, 87-100.
73. Root C. N., E. G. Wills, L. L. Mcnair, G. R. Whittaker (2000): Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor. J. Virol. 81, 2697-2705.
74. Rott, R., H. D. Klenk, Y. Nagai, M. Tashiro (1995): Influenza-Viruses, Cell Enzymes, and Pathogenicity. Am. J. Res.& Crit. Care Med. 152, S16-S19.
75. Samuel, C. E. (2001): Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809.
76. Schultz-Cherry, S., N. Dybdahl-Sissoko, M. McGregor, V. S. Hinshaw (1998): Mink lung epithelial cells: Unique cell line that supports influenza A and B virus replication. J. Clin. Microbiol. 36, 3718-3720.
77. Schultz-Cherry, S. N. Dybdahl-Sissoko, G. Neumann, Y. Kawaoka, V. S. Hinshaw (2001): Influenza virus NS1 protein induces apoptosis in cultured cells. J. Virol. 75, 7875-7881.
78. Schultz-Cherry, S. V. S. Hinshaw (1996): Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 70, 8624-8629.
79. Sebolt-Leopold, J. S., D. T. Dudley, R. Herrera, K. Van Becelaere, A. Wiland, R. C. Gowan, H. Tecle, S. D. Barrett, A. Bridges, S. Przybranowski, W. R. Leopold, A. R. Saltiel (1999): Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5, 810-816.
80. Senftleben, U., Y. X. Cao, G. T. Xiao, F. R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. L. Hu, A. Fong, S. C. Sun, M. Karin (2001): Activation by IKK alpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293, 1495-1499.
81. Seth, R. B., L. J. Sun, C. K. Ea, Z. J. J. Chen (2005): Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappa B and IRF3. Cell 122, 669-682.
82. Sharma, S., B. R. Tenoever, N. Grandvaux, G. P. Zhou, R. Lin, J. Hiscott (2003): Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151.
83. Sieczkarski, S. B., H. A. Brown, G. R. Whittaker (2001): The role of PKC beta II in influenza virus entry via late endosomes. Mol. Biol. Cell 12, 90A.
84. Sieczkarski, S. B., H. A. Brown, G. R. Whittaker (2003): Role of protein kinase C beta II in influenza virus entry via late endosomes. J. Virol. 77, 460-469.
85. Slee, E. A., M. T. Harte, R. M. Muck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, D. R. Green, S. J. Martin (1999): Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, - 8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292.
86. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, R. D. Schreiber (1998): How cells respond to interferons. Annual Rev. Biochem. 67, 227-264.
87. Takeda, K. S. Akira (2005): Toll-like receptors in innate immunity. Inter. Immunol. 17, 1-14.
88. Takizawa, T., S. Matsukawa, Y. Higuchi, S. Nakamura, Y. Nakanishi, R. Fukuda (1993): Induction of Programmed Cell-Death (Apoptosis) by Influenza-Virus Infection in Tissue-Culture Cells. J. Gen. Virol. 74, 2347-2355.
89. Takizawa, T., K. Ohashi, Y. Nakanishi (1996): Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J.Virol. 70, 8128-8132.
90. Takizawa, T., C. Tatematsu, K. Ohashi, Y. Nakanishi (1999): Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol.& Immunol. 43, 245-252.
91. Thornberry, N. A. Y. Lazebnik (1998): Caspases: Enemies within. Science 281, 1312-1316.
92. Tumpey, T. M., X. H. Lu, T. Morken, S. R. Zaki, J. M. Katz (2000): Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 74, 6105-6116.
93. Wang, X., M. Li, H. Zheng, T. Muster, P. Palese, A. A. Beg, A. Garcia-Sastre (2000): Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74, 11566-11573.
94. Wathelet, M. G., C. H. Lin, B. S. Parekh, L. V. Ronco, P. M. Howley, J. Maniatis (1998): Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1, 507-518.
95. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, D. V. Goeddel (1997): I kappa B kinase-beta: NF-kappa B activation and complex formation with I kappa B kinase-alpha and NIK. Science 278, 866-869.
96. Wurzer, W. J., C. Ehrhardt, S. Pleschka, F. Berberich-Siebelt, T. Wolff, H. Walczak, O. Planz, S. Ludwig (2004): NF-kappa B-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J. Biol. Chem. 279, 30931-30937.
97. Wurzer, W. J., O. Planz, C. Ehrhardt, M. Giner, T. Silberzahn, S. Pleschka, S. Ludwig (2003): Caspase 3 activation is essential for efficient influenza virus propagation. Embo J. 22, 2717-2728.
98. Xiao, G. T., M. E. Cvijic, A. Fong, E. W. Harhaj, M. T. Uhlik, M. Waterfield, S. C. Sun (2001): Retroviral oncoprotein Tax induces processing of NF-kappa B2/p100 in T cells: evidence for the involvement of IKK alpha. Embo J. 20, 6805-6815.
99. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. H. Zhai, H. B. Shu (2005): VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-740.
100. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, T. Fujita (2004): The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737.
101. Zamanian-Daryoush, M., T. H. Mogensen, J. A. DiDonato, B. R. G. Williams (2000): NF-kappa B activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappa B-inducing kinase and I kappa B kinase. Mol. & Cell. Biol. 20, 1278-1290.
102. Zhimov, O. P., T. E. Konakova, W. Garten, H. D. Klenk (1999): Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J. Virol. 73, 10158-10163.
103. Zhirnov, O. P., T. E. Konakova, T. Wolff, H. D. Klenk (2002): NS1 protein of influenza A virus down-regulates apoptosis. J. Virol. 76, 1617-1625.